Insider · CIK 0001670673
Ryan J Selhorn
Files at AYTU (AYTU BIOPHARMA, INC). First filing -, latest -.
In brief
Ryan J Selhorn files SEC Form 4 as CFO at AYTU (AYTU BIOPHARMA, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ryan J Selhorn has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 74,743 | Jul 30, 2026 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +16,243 | $0.00 | $0 | 32,243 | Oct 7, 2025 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +17,500 | $0.00 | $0 | 49,743 | Oct 7, 2025 |
| Feb 5, 2025 | AYTU AYTU BIOPHARMA, INC | MOption exercise Common Shares | +105 | - | - | 16,000 | Mar 3, 2025 |
| Feb 5, 2025 | AYTU AYTU BIOPHARMA, INC | MOption exercise Restricted Stock Unitsderivative | -105 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Nov 11, 2024 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Shares | +14,000 | $0.00 | $0 | 15,895 | Nov 13, 2024 |
Questions about Ryan J Selhorn
Answered from the filings on this page, as of the latest one.
Is Ryan J Selhorn buying or selling?
Ryan J Selhorn has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ryan J Selhorn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ryan J Selhorn has 0.
Where does Ryan J Selhorn file Form 4?
Ryan J Selhorn has filed Form 4 at AYTU (AYTU BIOPHARMA, INC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.